Our Hemodynamic-Peripheral Flow Patient Monitoring system uses a compact and versatile optical sensor to deliver superior physiological parameter measurement capabilities. Based on miniaturized dynamic light scattering (mDLS) technology and advanced algorithms for multi-parametric detection, our truly non-invasive solution offers continuous monitoring during surgery, recovery, and other critical care conditions such as low perfusion, shock/sepsis, and bleeding. The sensor readings are resistant to ambient light and not affected by skin pigmentation. Contrary to the PPG sensor that measures blood volume fluctuations, our proprietary solution measures blood flow and other hemodynamic parameters, opening the door to endless opportunities for new applications.
Our compact and non-invasive sensor is based on Miniaturized Dynamic Light Scattering (mDLS) technology and proprietary signal processing algorithms. The versatile sensor can be placed anywhere on the body and can effectively measure a range of cardiovascular and physiological parameters. This flexibility allows for numerous app integration possibilities, from wearable patches to implantable neuromodulation devices. The sensor is resistant to the most challenging ambient light conditions and is not affected by any skin pigmentations.
Reduced healthcare costs associated with peripheral blood flow monitoring are linked to shorter hospital stays, minimized intensive care resources, fewer diagnostic tests such as imaging studies and laboratory tests, reduced need for treatments such as mechanical ventilation and vasoactive medications, avoidance of secondary complications such as organ failure and fewer hospital readmissions.
Especially after surgeries or injuries that impact circulation, monitoring blood flow during exercise or therapy sessions can help optimize rehabilitation programs, ensuring that the interventions are tailored to the individual's needs and maximizing the effectiveness of treatment.
Identifying patients who are at high risk for complications from procedures. Early detection of reduced blood flow can assist in treatment modifications in a timely manner rather than in emergency or critical conditions.
Providing clinicians with objective data on an individual's circulatory health, to optimize medication management, lifestyle modifications, and interventions, resulting in better outcomes, reduced complications, and overall healthcare cost savings.
Providing a full picture of the patient status could allow for patients to be discharged from the hospital sooner. Form-factors with the integrated mDLS sensor enable exciting new home monitoring applications.
Early detection of critical ischemic episodes or worsening circulatory conditions can help prevent complications such as non-healing wounds, ulcers, infections and even limb amputation.
Identifying patients who are at risk for readmission and providing them with the appropriate interventions. Prior to releasing a patient, health care providers can more accurately evaluate the patient status and level of risk for deterioration.
Machine learning can create predictive models that can forecast a patient’s hemodynamic status, such as the risk of developing sepsis or shock, based on their vital signs, lab results, and other data. Machine learning can also analyze real-time hemodynamic data and alert healthcare providers of any abnormal changes, such as a sudden drop in blood pressure. These alarms can be managed to alert healthcare providers only when necessary, which can reduce alarm fatigue and improve patient care. Machine learning can also automatically diagnose hemodynamic conditions based on vital signs and other data, such as sepsis or hypovolemic shock, which can help to identify patients at risk of developing complications. These algorithms can be used to create personalized treatment plans based on a patient’s hemodynamic status and other factors, and can identify patterns in the data that are not obvious to the human eye, which can help to identify patients at risk of developing complications and to adjust therapy accordingly.
‘Elfi-Tech’s blood flow sensor has the potential to add a new dimension to our understanding of patient conditions in more detail’
‘By monitoring peripheral blood flow, we gain vital seconds or even minutes of warning prior to critical patient events’
© Copyright Elfi-Tech. 2023. All Rights Reserved.
Website by GROW.
Privacy Policy | Terms of use
If you are a dedicated team player with a passion for healthcare, apply here.
Rehovot, Israel | Full-time
Rehovot, Israel | Full-time
Rehovot, Israel | Full-time
Rehovot, Israel | Full-time
Rehovot, Israel | Full-time
Rehovot, Israel | Full-time
Once you click on the link above, you will be taken to a form on LinkedIn.
The free sensor form factor can be applied anywhere on the body with a custom adhesive sticker. Monitoring of peripheral blood flow and associated parameters can be done from anywhere on the body during a procedure or long term patient monitoring.
As a known form factor in the patient monitoring world, the mDLS sensor can easily be integrated into a pulse oximeter in order to add a new dimension of cardiovascular parameters.
Non-invasive blood circulation monitoring can assist in wound healing by:
Overall, blood circulation monitoring is a valuable tool that can help to improve the healing process for patients with wounds.
Peripheral hemodynamic monitoring can help clinicians optimize fluid management in patient care, particularly in critically ill or hospitalized patients. It can provide information about the patient’s cardiovascular status, including their cardiac output and peripheral vascular resistance; detect changes in peripheral perfusion, such as decreased blood flow to the extremities; and help identify patients who are at risk of developing complications related to poor peripheral perfusion, such as pressure ulcers or peripheral neuropathy. By identifying these patients early, clinicians can adjust fluid and medication therapies accordingly to maintain optimal cardiovascular function, prevent complications, and improve patient outcomes.
Continuous peripheral flow monitoring enables early detection of critical changes in physiological conditions, which can allow for early intervention and improved outcomes. The mDlS technology can provide important information about the patient’s condition that is not available with traditional hemodynamic monitoring methods. Peripheral microcirculation assessment is essential for monitoring the progression of chronic conditions such as peripheral artery disease, diabetes, and hypertension; for post-operative care, such as patients who have undergone revascularization procedures; and for monitoring wound healing such as diabetic foot ulcers or pressure ulcers. Other areas where peripheral blood flow assessment is necessary are in geriatric patients at risk of developing age-related conditions such as frailty; pediatric patients at risk of developing complications such as acute kidney injury; and in sports medicine for those at risk of developing exercise-induced injuries or conditions.
Non-invasive peripheral blood flow monitoring is a safe and effective way to assess the severity of peripheral artery disease (PAD) and monitor the response to treatment. Peripheral flow monitoring can be used before, during, and after a vascular intervention procedure to help ensure patient safety and optimize outcomes.
Benefits of Peripheral flow monitoring during an angioplasty procedure:
Benefits of Peripheral flow monitoring after a vascular intervention procedure:
Peripheral flow monitoring is a valuable tool for monitoring patients with PAD before, during, and after a vascular intervention procedure. It can help to ensure patient safety and optimize outcomes.